Brind.

Aurinia (Canada)'s CMO justified the use of a 24-week dosing schedule for its treatment.

1 report, 1 independent Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Aurinia (Canada)'s CMO justified the use of a 24-week dosing schedule for its treatment.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GuruFocus.comAurinia Pharmaceuticals Inc (AUPH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... Release Date: July 31, 2025 For the complete transcript of the earnings call, please refer to the fu